Morbidity and Mortality Weekly Report (MMWR)

This report describes the percentage of adults aged ≥50 years who ever received a shingles vaccine in the United States.

MMWR Erratum Volume 70, Number 14

This report describes disparities in fatal drowning rates among persons aged ≤29 years in the United States.

This report describes mental health among parents and caregivers of adults during the COVID-19 pandemic.

This report describes trends in hepatitis A cases among men who have sex with men.

As of May 2021, 16% of pregnant people identified in CDC's Vaccine Safety Datalink had received ≥1 dose of a COVID-19 vaccine during pregnancy in the U.S. Vaccination was lowest among Hispanic people (12%), non-Hispanic Black people (6%), and people aged 18-24 years (6%), and highest among non-Hispanic Asian people (25%) and people aged 35-49 years (23%).

During the COVID-19 pandemic, emergency department (ED) visits for suspected suicide attempts increased among adolescents aged 12-17 years, especially girls. During February-March 2021, suspected suicide attempt ED visits were 51% higher among girls aged 12-17 years than during 2019; among boys aged 12-17 years, suspected suicide attempt ED visits increased 4%.

This report describes trends in administered childhood and adolescent vaccinations during the COVID-19 pandemic.

This report describes rubella incidence in European regions for the years 2005 to 2019.

This report describes the percentage of children who wear glasses or contacts by age and sex.

This report describes surveillance for SARS-CoV-2 variants circulating in the United States.

By May 2021, 69%, 45%, and 26% of adults aged ≥65, 50-64, and 18-49 years were fully vaccinated. From November-December 2020 to April-May 2021, the rate ratios of COVID-19 incidence, emergency department visits, hospital admissions, and deaths among persons aged ≥65 (≥70 for hospitalizations) to persons aged 18-49 years declined 40%, 59%, 65%, and 66% respectively.

COVID-19 adolescent hospitalization rates peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 in mid-March, and rose to 1.3 in April. Among hospitalized adolescents, nearly one-third required intensive care unit admission and 5% required invasive mechanical ventilation, but no associated deaths occurred.

This report describes how HIV-positive patients with severe HIV disease were more likely to develop severe COVID-19 or die of COVID-19.

This report describes estimated HIV infections in the United States during 1981-2019.

This report describes the effect of policy, funding, and strategy changes on COVID-19 surveillance in the South Sudan.

This report describes the percentage of adults who are worried about paying medical bills when they get ill or have an accident.

Based on the national trend in ESRD deaths during the first 7 months of the U.S. COVID-19 pandemic (February-August 2020), an estimated 8.7-12.9 excess deaths per 1,000 patients or 6,953-10,316 excess deaths in a population of 798,611 U.S. ESRD patients occurred.

Disparities in county-level vaccination coverage by social vulnerability have increased as vaccine eligibility has expanded. By May 2021, vaccination coverage was lower among adults living in counties with low socioeconomic status and higher percentages of households with children, single parents, and people with disabilities.

This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex.

This report describes how Sub-Saharan African countries have overcome challenges to initiate and scale up HIV viral load testing to monitor patients receiving Antiretroviral therapy.

This report describes the impact of COVID-19 on HIV viral load testing in PEPFAR-supported countries.

This report describes racial/ethnic disparities in breastfeeding initiation across states.

As of April 30, 2021, approximately 101 million people in the U.S. had been fully vaccinated against COVID-19. Almost 10,300 COVID-19 vaccine breakthrough infections were reported from 46 states and territories. Vaccine breakthrough infections occur in only a small fraction of all vaccinated people.

Utah implemented two high school COVID-19 testing programs to sustain in-person instruction and extracurricular activities. During November 30, 2020-March 20, 2021, among 59,552 students who received testing, 1,886 (3.2%) had a positive result. These programs facilitated the completion of approximately 95% of high school athletic events and saved an estimated 109,752 in-person instruction student-days.

COVID-19 incidence was 37% lower in schools that required teachers and staff to use masks and 39% lower in schools that improved ventilation. Ventilation strategies associated with lower school incidence included dilution methods alone (35% lower incidence) or in combination with filtration methods (48% lower incidence).

This report describes death rates for falls, motor vehicle traffic, firearms, and drug poisonings in the United States.

This report describes COVID-19 cases and outbreaks in child care facilities in the District of Columbia.

This report describes outbreaks caused by pathogens or chemicals in treated recreational water.

This report describes updated recommendations for the use of self-administered injectable contraception.

COVID-19 vaccination coverage was lower in rural counties (38.9%) than in urban counties (45.7%); disparities persisted among age groups and by sex.

The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.

In May 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years for the prevention of COVID-19.

After the first 3.5 months of the U.S. COVID-19 vaccination program, 79.1% of adults aged ≥65 years had received ≥1 dose, with higher vaccination initiation among men. Counties with lower vaccination initiation rates had higher percentages of older adults with social vulnerabilities.

This report describes how COVID-19 community-based testing programs can help reach underrepresented groups with limited access to testing.

This report describes the prevalence of Inflammatory Bowel Disease among Medicare fee-for-service beneficiaries aged ≥67 years.

This report describes the performance of the Quidel rapid antigen SARS-CoV-2 test in a hospital setting.

This report describes emergency department visits for bicycle-related traumatic brain injuries during 2009-2018.

Data from six models indicate that with high vaccination coverage and moderate nonpharmaceutical intervention (NPI) adherence, hospitalizations and deaths will likely remain low nationally, with a sharp decline in cases projected by July 2021. Lower NPI adherence could lead to substantial increases in severe COVID-19 outcomes, even with improved vaccination coverage

The NYC Department of Health and Mental Hygiene analyzed laboratory and epidemiologic data to characterize cases of B.1.526 infection and the associated potential for breakthrough infection and reinfection. Preliminary evidence suggests that, to date, B.1.526 does not lead to more severe disease or increased risk for infection after vaccination.

On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system.

This report describes the percentage of adults with diabetes by urbanization level and age group in the United States.

This report describes the number of emergency department visits and hospitalizations occurring among older adults from falls and other accidents.

This report describes an outbreak of Escherichia coli in multiple states linked to romaine lettuce.

This report describes an analysis of polio surveillance data from 42 countries during 2019-2020.

Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.

Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.

In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.

This report describes healthcare use among adolescents with autism.

This report describes emergency department visits attributed to tick bites.